IDIQ: chemistry, manufacturing, and control (CMC) and related services for drug products
Active Awarded Last action
- Contract number
- 75N95024D00017
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products Pre-Solicitation · 75N95023R00037 · Posted May 30, 2023
- Last date to order 32% complete
- IDV ceiling
- $49,885,703.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Fisher Bioservices Inc. Clinical Trials Division on August 1, 2024, with a ceiling value of $49,885,703 and an ultimate completion date of July 31, 2031. This is an unset-aside, full-and-open procurement.
Work covers chemistry, manufacturing, and control (CMC) and related services for drug products, issued under Executive Order 14398. Place of performance follows the scope of the originating solicitation, which was posted May 30, 2023, with a pre-solicitation due date of June 14, 2023.
The contract runs through July 31, 2031. The ceiling is $49,885,703 with no stated minimum guarantee. The IDIQ is structured as one of multiple awards under the parent vehicle "Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products."
Fisher Bioservices Inc. Clinical Trials Division operates without SBA certifications and competes in full-and-open procurements. The division's service portfolio centers on biospecimen repository management, storage, maintenance, and distribution of biological specimens, cell lines, clinical trial materials, and pharmaceutical compounds across multiple storage environments including ultra-low freezers, liquid nitrogen, refrigerated, and controlled room temperature conditions. The division self-performs substantially all work with minimal subcontractor engagement.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00017?
75N95024D00017 was awarded to Fisher Bioservices Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024D00017 worth?
75N95024D00017's own ceiling is $49,885,703.
Who can order from contract 75N95024D00017?
75N95024D00017 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00017 part of a contract vehicle?
Yes. 75N95024D00017 is part of Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products.
Was contract 75N95024D00017 competed?
The extent of competition for 75N95024D00017 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV